Dna X (SONM) Revenue (2018 - 2025)

Dna X's Revenue history runs 8 years deep, the most recent figure standing at $16.2 million for Q3 2025.

• Quarterly Revenue rose 7.94% year-over-year to $16.2 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $51.7 million (down 8.84% YoY) and the FY2024 annual result came in at $50.9 million, down 45.62% from the prior year.
• Revenue was $16.2 million for Q3 2025 at Dna X, up from $11.2 million in the prior quarter.
• Across five years, Revenue topped out at $27.6 million in Q3 2023 and bottomed at $7.6 million in Q4 2024.
• A 5-year average of $16.5 million and a median of $15.0 million in 2024 frame the typical range for Revenue.
• Annual changes were most pronounced in 2023 — Revenue jumped 124.47% — and 2024, when it plunged 57.09%.
• Dna X's Revenue stood at $15.9 million in 2021, then jumped by 51.39% to $24.1 million in 2022, then slumped by 44.32% to $13.4 million in 2023, then slumped by 43.37% to $7.6 million in 2024, then soared by 113.2% to $16.2 million in 2025.
• Business Quant data shows SONM's Revenue at $16.2 million in Q3 2025, $11.2 million in Q2 2025, and $16.7 million in Q1 2025.